Google
SPTX — SEAPORT THERAPEUTICS, INC. (Healthcare >> Biotechnology)
SPTX FAQ
What is SPTX's ROE?
SEAPORT THERAPEUTICS, INC. reports a Return on Equity (ROE) of 0.00%.
What is SPTX's dividend yield?
SEAPORT THERAPEUTICS, INC. offers a dividend yield of 0.00%.
What is SPTX's Deepscope Quality Score?
Deepscope rates SPTX's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy SPTX?
Deepscope's AI Timing Score for SPTX is 74 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does SPTX belong to?
SEAPORT THERAPEUTICS, INC. is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 16.44
Price
-1.44
(-8.05%)
Day Change
|
|
|---|
SPTX, the overall quality is not good ( Quality = 38) but the timing to buy is ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Negative growth of ROE in the last year.
ROE is decreasing significantly
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Quality Factors |
|
44% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 53 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 16.44 |
| PBV / Sector |
4.25 / 4.63
|
| Earning Per Share | N/A |
| PE / Sector |
N/A / 17.43
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
4.07 M
GREAT
|
| Average 1W Daily Value |
2.02 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
43% |
| Ability to Make Profit |
|
37% |
| Return to Investors |
|
8% |
| Registration Details |
| Analyze Date | 2026-06-06 09:09:21 |
| Symbol | SPTX |
| Name | SEAPORT THERAPEUTICS, INC. |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 53.03 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 913.67 / 8,857.28 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 101 Seaport Blvd., Boston, MA, United States, 02210-2186
Phone: (617) 807-4062
Website: https://www.seaporttx.com
Employees: 58
Sector: Healthcare >> Biotechnology
Description: Seaport Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines. The company develops therapeutic candidates for conditions such as depression and anxiety disorders using its proprietary Glyph technology platform. The Glyph platform is designed to enable oral bioavailability, bypass first-pass metabolism, and reduce liver enzyme elevations or hepatotoxicity and other side effects. All therapeutic candidates in development are based on this platform, with research and development activities focused on neuropsychiatric medicines. The company serves clinicians and key opinion leaders in the healthcare and neuropsychiatric medicine sectors. The company was founded in 2024 and is based in Boston, Massachusetts.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
